Affirm CFO sells 21,631 shares under 10b5-1 plan
Affirm’s CFO exercised RSUs and sold about 21,600 shares under a pre-set Rule 10b5-1 trading plan at roughly $71–$74 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Affirm Holdings, Inc. (AFRM) reported that Chief Financial Officer Robert O'Hare exercised restricted stock units into 11,987 shares of Class A Common Stock on September 1, 2026, with 6,101 shares withheld to cover tax obligations.
O'Hare then sold a total of 21,631 shares of Class A Common Stock on September 1–2, 2026 at weighted average prices around $71–$74 per share, with the sales made pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock F2, F5 | 5,886 | $74.02 | $436K |
| Exercise | Restricted Stock Units F6, F7 | 702 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F6, F8 | 5,019 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F6, F9 | 2,128 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F6, F10 | 1,357 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F6, F11 | 2,781 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 11,987 | $0.00 | $0.00 |
| Tax Withholding | Class A Common Stock F1 | 6,101 | $69.94 | $427K |
| Sale | Class A Common Stock F2, F3 | 15,545 | $71.59 | $1.11M |
| Sale | Class A Common Stock F2, F4 | 200 | $72.51 | $15K |
Footnotes (11)
- F1. Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the settlement of shares of Common Stock underlying the Reporting Person's restricted stock units that vested on September 1, 2026.
- F2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2026.
- F3. Represents the weighted average sale price of the shares sold from $71.25 to $72.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. Represents the weighted average sale price of the shares sold from $72.51 to $72.54 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. Represents the weighted average sale price of the shares sold from $73.84 to $74.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F7. The RSUs vested in equal monthly installments from October 1, 2022 until August 1, 2023. Beginning September 1, 2023, the RSUs vest in equal quarterly installments, subject to the Reporting Person's continued employment with the Issuer as of each vesting date. This grant has no expiration date.
- F8. The RSUs vest as to 25% of the shares on September 1, 2024 and the remainder vest in 12 equal quarterly installments over the subsequent three years, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. This grant has no expiration date.
- F9. The RSUs vest as to 25% of the shares on September 1, 2025 and the remainder vest in 12 equal quarterly installments over the subsequent three years, subject to the Reporting Person's continuous service with the Issuer as of each vesting date. This grant has no expiration date.
- F10. The RSUs vest in equal quarterly installments for a period of four years beginning December 1, 2024, the vesting commencement date, subject to the Reporting Person's continued employment with the Issuer as of each vesting date.
- F11. The RSUs vest in equal quarterly installments for a period of three years beginning December 1, 2025, the vesting commencement date, subject to the Reporting Person's continued employment with the Issuer as of each vesting date.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Restricted Stock Unit (RSU) financial
weighted average sale price financial
vesting commencement date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did AFRM CFO Robert O'Hare have vest on September 1, 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.